Liposomal Bupivacaine in Total Knee Arthroplasty for Better Postoperative Analgesic Outcome and Economic Benefits

Abstract

When orthopedists consider which analgesia to use after total knee arthroplasty (TKA), the primary objective is to relieve pain with fewer adverse side effects. Over the last decade, substantial efforts have been made to improve pain control following TKA, but it is still very challenging to obtain optimal control. Current modalities in use, such as opioids, epidurals, and nerve blocks, provide substantial pain relief, but they are associated with substantial side effects and serious complications. Recently, bupivacaine, a commonly used nonopioid analgesic, has been formulated into an aqueous suspension of multivesicular liposomes that provide long-lasting analgesia, while avoiding significant adverse effects of opioids. The purpose of this review is to analyze the use of traditional postsurgical pain management and the potential contribution of a long-acting liposomal formulation of bupivacaine as part of the analgesic regimen in TKA, including its mode of action, injection technique, efficacy on pain, and health care costs.

Keywords

liposomal bupivacaine - total knee arthroplasty - analgesia - pain

• References

• 1 Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am 2007; 89 (4) 780-785
• 2 Apfelbaum JL, Chen C, Mehta SS, Gan TJ. Postoperative pain experience: results from a national survey suggest postoperative pain continues to be undermanaged. Anesth Analg 2003; 97 (2) 534-540
• 3 Oderda GM, Gan TJ, Johnson BH, Robinson SB. Effect of opioid-related adverse events on outcomes in selected surgical patients. J Pain Palliat Care Pharmacother 2013; 27 (1) 62-70
• 4 Kessler ER, Shah M, Gruschkus SK, Raju A. Cost and quality implications of opioid-based postsurgical pain control using administrative claims data from a large health system: opioid-related adverse events and their impact on clinical and economic outcomes. Pharmacotherapy 2013; 33 (4) 383-391
• 5 Barrington JW, Dalury DF, Emerson Jr RH, Hawkins RJ, Joshi GP, Stulberg BN. Improving patient outcomes through advanced pain management techniques in total hip and knee arthroplasty. Am J Orthop 2013; 42 (10, Suppl): S1-S20
• 6 Bergese SD, Onel E, Portillo J. Evaluation of DepoFoam(®) bupivacaine for the treatment of postsurgical pain. Pain Manag 2011; 1 (6) 539-547
• 7 Surdam JW, Licini DJ, Baynes NT, Arce BR. The use of exparel (liposomal bupivacaine) to manage postoperative pain in unilateral total knee arthroplasty patients. J Arthroplasty 2015; 30 (2) 325-329
• 8 Bagsby DT, Ireland PH, Meneghini RM. Liposomal bupivacaine versus traditional periarticular injection for pain control after total knee arthroplasty. J Arthroplasty 2014; 29 (8) 1687-1690
• 9 Bramlett K, Onel E, Viscusi ER, Jones K. A randomized, double-blind, dose-ranging study comparing wound infiltration of DepoFoam bupivacaine, an extended-release liposomal bupivacaine, to bupivacaine HCl for postsurgical analgesia in total knee arthroplasty. Knee 2012; 19 (5) 530-536
• 10 Halawi MJ, Vovos TJ, Green CL , et al. Opioid-based analgesia: impact on total joint arthroplasty. J Arthroplasty 2015; 30 (12) 2360-2363
• 11 Oderda GM, Said Q, Evans RS , et al. Opioid-related adverse drug events in surgical hospitalizations: impact on costs and length of stay. Ann Pharmacother 2007; 41 (3) 400-406
• 12 Oderda G. Challenges in the management of acute postsurgical pain. Pharmacotherapy 2012; 32 (9, Suppl): 6S-11S
• 13 Ilfeld BM, Morey TE, Enneking FK. Portable infusion pumps used for continuous regional analgesia: delivery rate accuracy and consistency. Reg Anesth Pain Med 2003; 28 (5) 424-432
• 14 Ilfeld BM, Duke KB, Donohue MC. The association between lower extremity continuous peripheral nerve blocks and patient falls after knee and hip arthroplasty. Anesth Analg 2010; 111 (6) 1552-1554
• 15 Ilfeld BM, Malhotra N, Furnish TJ, Donohue MC, Madison SJ. Liposomal bupivacaine as a single-injection peripheral nerve block: a dose-response study. Anesth Analg 2013; 117 (5) 1248-1256
• 16 Wright CS, Kaku H, Goldstein IJ. Crystallization and preliminary X-ray diffraction results of snowdrop (Galanthus nivalis) lectin. J Biol Chem 1990; 265 (3) 1676-1677
• 17 The Best Infiltration Practices Working Group. Best infiltration practices: local analgesia infiltration techniques – hip & knee arthroplasty. Lake Mary, FL:
• 18 Lonner JH, Scuderi GR, Lieberman JR. Potential utility of liposome bupivacaine in orthopedic surgery. Am J Orthop 2015; 44 (3) 111-117
• 19 Lombardi Jr AV. Recent advances in incorporation of local analgesics in postsurgical pain pathways. Am J Orthop 2014; 43 (10, Suppl): S2-S5
• 20 Broome CB, Burnikel B. Novel strategies to improve early outcomes following total knee arthroplasty: a case control study of intra articular injection versus femoral nerve block. Int Orthop 2014; 38 (10) 2087-2089
• 21 Emerson RH, Barrington JW. Comparison of infiltration with long-acting bupivacaine to a femoral nerve catheter for total knee replacement. Paper presented at: 2014 Annual Meeting of the American Academy of Orthopaedic Surgeons; March 2014; New Orleans, LA
• 22 Barrington JW, Olugbode O, Lovald S, Ong K, Watson H, Emerson Jr RH. Liposomal bupivacaine: a comparative study of more than 1000 total joint arthroplasty cases. Orthop Clin North Am 2015; 46 (4) 469-477
• 23 Webb BT, Spears JR, Langan SS, Malkani AL. Periarticular injection of liposomal bupivacaine in total knee arthroplasty. Paper presented at 2015 Annual Meeting of the American Academy of Orthopaedic Surgeons; March 2015; Las Vegas, NV
• 24 Schroer WC, Diesfeld PG, LeMarr AR, Morton DJ, Reedy ME. Does extended-release liposomal bupivacaine better control pain than bupivacaine after total knee arthroplasty (TKA)? A prospective, randomized clinical trial. J Arthroplasty 2015; 30: 64-67
• 25 White S, Vaughan C, Raiff D, Eward W, Bolognesi M. Impact of liposomal bupivacaine administration on postoperative pain in patients undergoing total knee replacement. Pharmacotherapy 2015; 35 (5) 477-481
• 26 Asche CV, Kirkness CS, Ren J, Kim M, Rainville E. The economic benefit of bupivacaine liposome injectable suspension in the management of postsurgical pain for total knee arthroplasty. Poster presented at Academy of Managed Care Pharmacy, Orlando, Florida; 2015
• 27 Springer BD, Bear S, Christian EP. Thinking Beyond Hospital Pharmacy Silo Analysis of Perioperative Pain Modalities in Total Joint Arthroplasty. Paper presented at: 2015 Annual Meeting of the American Academy of Orthopaedic Surgeons; March 2015; Las Vegas, NV